Rhinocort

Proteinuria, Asthma, Itching + 16 more

Treatment

20 Active Studies for Rhinocort

What is Rhinocort

Budesonide

The Generic name of this drug

Treatment Summary

Budesonide is a steroid used to treat various types of inflammation, such as asthma, COPD, Crohn's disease, and ulcerative colitis. It was approved by the FDA in 1994 and is available in both oral and inhaled forms.

Rhinocort

is the brand name

image of different drug pills on a surface

Rhinocort Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rhinocort

Budesonide

1994

134

Effectiveness

How Rhinocort Affects Patients

Budesonide is a medication used to help reduce inflammation in respiratory and digestive issues. The dose of budesonide needed varies from person to person, so it is important for patients to discuss their individual risks of developing high levels of cortisol (hypercorticism) or suppressing the adrenal axis.

How Rhinocort works in the body

Corticosteroids are a type of medication that reduce inflammation. They work by binding to special receptors in the body and changing how genes are expressed. This causes several effects, such as blocking white blood cells from flowing to sites of inflammation and decreasing the production of molecules that cause inflammation. Lower doses of corticosteroids reduce inflammation, while higher doses can suppress the immune system. Over time, these higher doses can also affect levels of sodium and potassium in the body.

When to interrupt dosage

The proposed dosage of Rhinocort is contingent upon the diagnosed sickness, encompassing Vasomotor Rhinitis, Crohn's Disease and Chronic Obstructive Pulmonary Disease (COPD). The quantity of dosage is contingent upon the technique of administration (e.g. Enema; Kit; Tablet - Rectal or Respiratory (inhalation)) as noted in the table below.

Condition

Dosage

Administration

Acute Coryza

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Colitis, Collagenous

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Itching

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

IGA Glomerulonephritis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Rhinitis, Vasomotor

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Crohn Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Eosinophilic Esophagitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Proteinuria

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Asthma

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Skin Diseases

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Hypersensitivity

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Ulcerative Colitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Nasal Polyps

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Crohn's Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Nasal Congestion

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Sinusitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Crohn Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Chronic Obstructive Pulmonary Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

maintenance therapy

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet, Enema; Kit; Tablet - Rectal, Capsule, extended release - Oral, Capsule, extended release, Capsule, coated pellets - Oral, Capsule, coated pellets, Powder - Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Nasal; Respiratory (inhalation), Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Powder, metered - Respiratory (inhalation), Powder, metered, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Cutaneous, Kit, Kit - Rectal, Aerosol, metered - Respiratory (inhalation), Patch - Cutaneous, Patch, Capsule, delayed release - Oral, Capsule, delayed release

Warnings

Rhinocort has five contraindications and should be avoided if you encounter any of the conditions in the following table.

Rhinocort Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Severe Hepatic Impairment

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

There are 20 known major drug interactions with Rhinocort.

Common Rhinocort Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abatacept

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Budesonide.

Abetimus

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abetimus.

Rhinocort Toxicity & Overdose Risk

It is uncommon for someone to experience an acute overdose of corticosteroids, but taking them in high doses for an extended period of time can cause an excess of the hormones and suppress the adrenal axis. If an overdose does occur, the dosage of corticosteroids should be reduced temporarily. 200mg of corticosteroids is fatal for female mice and 400mg is fatal for male mice.

image of a doctor in a lab doing drug, clinical research

Rhinocort Novel Uses: Which Conditions Have a Clinical Trial Featuring Rhinocort?

516 active trials are assessing the potential of Rhinocort to ameliorate Chronic Obstructive Pulmonary Disease (COPD), Ulcerative Colitis and Allergic symptoms.

Condition

Clinical Trials

Trial Phases

Itching

4 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1

Chronic Obstructive Pulmonary Disease

73 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4

Asthma

87 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Proteinuria

6 Actively Recruiting

Phase 2, Phase 3, Phase 4, Phase 1, Not Applicable

IGA Glomerulonephritis

0 Actively Recruiting

Ulcerative Colitis

23 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable, Phase 4

Sinusitis

0 Actively Recruiting

Crohn's Disease

54 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Phase 3, Phase 4, Early Phase 1

Hypersensitivity

1 Actively Recruiting

Phase 4

Colitis, Collagenous

0 Actively Recruiting

Skin Diseases

0 Actively Recruiting

maintenance therapy

0 Actively Recruiting

Rhinitis, Vasomotor

1 Actively Recruiting

Not Applicable

Eosinophilic Esophagitis

0 Actively Recruiting

Acute Coryza

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Nasal Polyps

1 Actively Recruiting

Not Applicable

Crohn Disease

0 Actively Recruiting

Nasal Congestion

1 Actively Recruiting

Phase 2

Rhinocort Reviews: What are patients saying about Rhinocort?

5

Patient Review

4/28/2013

Rhinocort for Allergic Rhinitis Prevention

I've found this treatment to be effective and much gentler on my nose than Flonase, which would sometimes give me bloody noses.

5

Patient Review

10/11/2016

Rhinocort for Allergic Rhinitis Prevention

Rhinocort is vastly superior to Flonase in my opinion. It doesn't gave me headaches, and the effects last much longer throughout the day. I also don't have any issues with taste or dryness, which were both common problems I had when using Flonase.

5

Patient Review

12/23/2010

Rhinocort for Inflammation of the Nose due to an Allergy

I experience dizziness when using this product; however, it has helped to reduce the inflammation I was experiencing.

5

Patient Review

10/11/2016

Rhinocort for Allergic Rhinitis Prevention

I've had allergies my whole life, and this nasal spray is by far the best option I've found.

5

Patient Review

7/4/2017

Rhinocort for Inflammation of the Nose due to an Allergy

I've been using this product for a while now and it has definitely made a difference for me. I used to have to take allergy shots twice a week, but this spray has worked so well that I don't need them anymore.

5

Patient Review

4/28/2010

Rhinocort for Inflammation of the Nose due to an Allergy

4.3

Patient Review

10/31/2014

Rhinocort for Inflammation of the Nose due to an Allergy

I've been using this medication for four months as recommended by my doctor. I can definitely see a positive effect; my sinuses have improved and I experience less nosebleeds. Plus, my allergies don't seem to be as bad as they used to be.

4

Patient Review

3/15/2016

Rhinocort for Allergic Rhinitis Prevention

I've only been using this for a short while, but it's already miles ahead of the nasalcort I tried previously. That gave me nasty nosebleeds, whereas this has no bad aftertaste and seems to be working quite well. I stick to one spray per nostril to avoid any potential nosebleeds, and so far that's been fine.

4

Patient Review

4/16/2013

Rhinocort for Allergic Rhinitis Prevention

I noticed a significant difference in my breathing after only a few days of using this product.

2.3

Patient Review

4/13/2020

Rhinocort for Inflammation of the Nose due to an Allergy

Long-term use of this drug is dangerous. I realized what was happening to me after two years: mild asthma, anxiety, wheezing, and heel pain in both legs. I stopped using the drug for a few days and saw an immediate relief.

1.7

Patient Review

7/22/2018

Rhinocort for Chronic Inflammation of the Nose Not due to Allergies

Unfortunately, this was the only nasal spray that made me feel more congested after using it.

1.7

Patient Review

4/19/2010

Rhinocort for Allergic Rhinitis Prevention

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about rhinocort

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Rhinocort being discontinued?

"is the last updated date for the Rhinocort brand name. If the FDA has approved generic versions of this product, then there may be generic equivalents available."

Answered by AI

Is Rhinocort the same as Flonase?

"Rhinocort and Flonase are two corticosteroid medications that can treat allergy symptoms. Flonase is more potent than Rhinocort, however they are both effective at reducing inflammation and treating symptoms such as a stuffy or itchy nose, and watery eyes."

Answered by AI

What is Rhinocort used to treat?

"Rhinocort Aqua is a steroid nasal spray used to treat Nasal Congestion, Sneezing, Runny Nose, and nasal polyps caused by allergies."

Answered by AI

What is better Rhinocort or Nasonex?

"Nasonex (Mometasone) and Rhinocort Aqua (Budesonide) are both good options for treating a stuffy or runny nose caused by allergies. Nasonex relieves nasal allergy symptoms and is a good first choice for treatment. Rhinocort Aqua is a steroid nasal spray that works best when used regularly."

Answered by AI

Clinical Trials for Rhinocort

Image of Cedars Sinai Medical Offices East Tower in Los Angeles, United States.

Active VR for Anxiety During ENT Procedures

18+
All Sexes
Los Angeles, CA

The purpose of this research is to evaluate whether active virtual reality reduces pain and anxiety more effectively than passive virtual reality during office-based ENT procedures. The main procedures include exposure to virtual reality (passive calming scenery or interactive puzzle game) via Paperplane Therapeutics software with VR headset or glasses during common in-office ENT procedures, participant self-report surveys (GAD-7, PHQ-9, PEG, VAS, SUDS, Likert, experience questions), and physician post-procedure survey. The study will enroll individuals 18 years or older who are scheduled to undergo common office-based ENT procedures (turbinate reduction, nasal debridement, balloon sinuplasty, radiofrequency ablation, nasal polypectomy, eustachian tube dilation, vocal fold injection, or subglottic steroid injection) at Cedars Sinai.

Waitlist Available
Has No Placebo

Cedars Sinai Medical Offices East Tower

Image of Cliantha Research in Mississauga, Canada.

Oxymetazoline Nasal Gel for Stuffy Nose

18 - 65
All Sexes
Mississauga, Canada

Nasal congestion (a "stuffy nose") is a common symptom of colds and seasonal or year-round allergies. It happens when the tiny blood vessels and tissues inside the nose swell and leak fluid, producing more mucus. That swelling and extra fluid make the nasal passages narrower, which can make it hard to breathe through the nose, sleep, or do daily activities. Oxymetazoline works on alpha-adrenergic receptors in the tiny blood vessels inside the nose. When these receptors are activated, the blood vessels tighten (constrict), which helps reduce swelling and open the nasal passages. The study drug, oxymetazoline hydrochloride (HCl) 0.05% nasal gel, is a gel form of a well-known decongestant that is typically available as a nasal spray. The gel may remain in contact with the nose longer than a spray and could feel different to use. The main purpose of this study is to learn how well a single dose of oxymetazoline HCl 0.05% nasal gel relieves nasal congestion within the first 2 hours after dosing using two different measures. The study will also look at safety and how well people tolerate the gel.

Phase 2
Recruiting

Cliantha Research

Bayer

Have you considered Rhinocort clinical trials?

We made a collection of clinical trials featuring Rhinocort, we think they might fit your search criteria.
Go to Trials
Image of Resilient Roots: Functional Medicine in Charlottesville, United States.

Ketogenic and Carnivore Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

18 - 64
All Sexes
Charlottesville, VA

This study is a randomized controlled clinical trial evaluating whether two therapeutic dietary approaches - a ketogenic diet and a carnivore (lion) diet - can improve quality of life, reduce symptoms, and influence measures of disease activity in adults with inflammatory bowel disease \[ulcerative colitis and Crohn's disease\] (IBD) or rheumatoid arthritis (RA). Participants will be randomized into one of three groups: 1) Ketogenic Diet, 2) Carnivore (Lion) Diet or 3) Wait-List Control. Participants randomized to a dietary group (ketogenic diet or carnivore diet) will be provided guidance on their specific dietary therapy and answer questions about their symptoms and quality of life at different intervals over a 24 week period. Participants will also complete laboratory testing at different intervals to assess for changes in nutritional status, cardiometabolic health and markers of immune activation and inflammation. Participants initially placed on the wait-list group will be asked similar questions about their symptoms and quality of life and complete the same laboratory testing as participants in a dietary group. Participants on the wait list will then be compared to participants following a specific dietary pattern to assess for any differences between the 2 groups. After 12 weeks, participants on the wait list will be randomized to a dietary group (ketogenic diet or carnivore diet) and followed in a similar fashion for an additional 12 week period.

Recruiting
Has No Placebo

Resilient Roots: Functional Medicine

Robert D Abbott, MD

Image of UCSF Medical Center in San Francisco, United States.

Upadacitinib for Ulcerative Colitis

18 - 75
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if the oral medication upadacitinib can safely and effectively treat acute severe ulcerative colitis (ASUC) in adults who are hospitalized. It will also evaluate whether upadacitinib can be used without corticosteroids during initial treatment. The main questions it aims to answer are: 1. Does upadacitinib reduce treatment failure by Day 14 (defined as need for colectomy or rescue therapy)? 2. What side effects and safety events occur when using upadacitinib in hospitalized patients with ASUC? Researchers will compare outcomes in participants receiving upadacitinib to a historical group of similar patients previously treated with standard therapies, including intravenous corticosteroids and infliximab, to determine if upadacitinib improves outcomes. Participants will: 1. Take oral upadacitinib once daily during hospitalization. 2. Undergo routine clinical monitoring, including blood tests and symptom assessments. 3. Be followed after discharge with clinic visits or phone calls for up to 12 months to assess outcomes such as need for additional treatment, surgery, and safety events

Phase 4
Waitlist Available

UCSF Medical Center

Sara Lewin, MD

AbbVie

Have you considered Rhinocort clinical trials?

We made a collection of clinical trials featuring Rhinocort, we think they might fit your search criteria.
Go to Trials

Have you considered Rhinocort clinical trials?

We made a collection of clinical trials featuring Rhinocort, we think they might fit your search criteria.
Go to Trials